NM_000044.6:c.1440dupC
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000044.6(AR):c.1440dupC(p.Tyr481LeufsTer21) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. Y481Y) has been classified as Benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000044.6 frameshift
Scores
Clinical Significance
Conservation
Publications
- androgen insensitivity syndromeInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- Kennedy diseaseInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- partial androgen insensitivity syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- complete androgen insensitivity syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000044.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AR | NM_000044.6 | MANE Select | c.1440dupC | p.Tyr481LeufsTer21 | frameshift | Exon 1 of 8 | NP_000035.2 | ||
| AR | NM_001348063.1 | c.1440dupC | p.Tyr481LeufsTer21 | frameshift | Exon 1 of 4 | NP_001334992.1 | |||
| AR | NM_001348061.1 | c.1440dupC | p.Tyr481LeufsTer21 | frameshift | Exon 1 of 4 | NP_001334990.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AR | ENST00000374690.9 | TSL:1 MANE Select | c.1440dupC | p.Tyr481LeufsTer21 | frameshift | Exon 1 of 8 | ENSP00000363822.3 | ||
| AR | ENST00000396044.8 | TSL:1 | c.1440dupC | p.Tyr481LeufsTer21 | frameshift | Exon 1 of 5 | ENSP00000379359.3 | ||
| AR | ENST00000504326.5 | TSL:1 | c.1440dupC | p.Tyr481LeufsTer21 | frameshift | Exon 1 of 4 | ENSP00000421155.1 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
Androgen resistance syndrome;C1839259:Kennedy disease Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, loss-of-function variants in AR are known to be pathogenic (PMID: 9463997, 20150575). This sequence change inserts 1 nucleotide in exon 1 of the AR mRNA (c.1440dupC), causing a frameshift at codon 481. This creates a premature translational stop signal (p.Tyr481Leufs*21) and is expected to result in an absent or disrupted protein product.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at